Augmedix (AUGX)
(Delayed Data from NSDQ)
$0.92 USD
+0.01 (0.94%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $0.92 0.00 (0.37%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth A Momentum C VGM
Balance Sheet
Fiscal Year End for Augmedix, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 46 | 21 | 41 | 23 | 12 |
Receivables | 9 | 6 | 7 | 3 | 2 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 2 | 2 | 2 | 1 | 0 |
Total Current Assets | 57 | 30 | 50 | 27 | 14 |
Net Property & Equipment | 4 | 2 | 1 | 1 | 1 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 1 | 1 | 0 | 0 | 0 |
Total Assets | 67 | 34 | 52 | 28 | 16 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 7 | 3 |
Accounts Payable | 1 | 2 | 1 | 0 | 1 |
Current Portion Long-Term Debt | 5 | 4 | 2 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 7 | 5 | 4 | 3 | 3 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 10 | 8 | 7 | 6 | 7 |
Total Current Liabilities | 24 | 19 | 14 | 16 | 13 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 15 | 11 | 13 | 8 | 10 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 1 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 58 |
Total Liabilities | 43 | 32 | 28 | 25 | 81 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 169 | 128 | 125 | 87 | 3 |
Retained Earnings | -145 | -126 | -102 | -84 | -68 |
Other Equity | -1 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 23 | 1 | 24 | 3 | -65 |
Total Liabilities & Shareholder's Equity | 67 | 34 | 52 | 28 | 16 |
Total Common Equity | 23 | 1 | 24 | 3 | -65 |
Shares Outstanding | 41.30 | 37.40 | 37.10 | NA | NA |
Book Value Per Share | 0.56 | 0.04 | 0.64 | 0.00 | 0.00 |
Fiscal Year End for Augmedix, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 37 | 46 | 22 | 25 |
Receivables | NA | 10 | 9 | 9 | 9 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 3 | 2 | 2 | 2 |
Total Current Assets | NA | 50 | 57 | 33 | 36 |
Net Property & Equipment | NA | 4 | 4 | 3 | 3 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 1 | 1 | 1 | 2 |
Total Assets | NA | 60 | 67 | 41 | 44 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 1 | 1 | 2 | 2 |
Current Portion Long-Term Debt | NA | 8 | 5 | 8 | 5 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 4 | 7 | 5 | 5 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 10 | 10 | 8 | 8 |
Total Current Liabilities | NA | 25 | 24 | 25 | 21 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 13 | 15 | 13 | 15 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 1 | 1 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 42 | 43 | 40 | 40 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 170 | 169 | 142 | 141 |
Retained Earnings | NA | -151 | -145 | -140 | -136 |
Other Equity | NA | -1 | -1 | -1 | -1 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 18 | 23 | 1 | 4 |
Total Liabilities & Shareholder's Equity | NA | 60 | 67 | 41 | 44 |
Total Common Equity | 0 | 18 | 23 | 1 | 4 |
Shares Outstanding | 48.90 | 48.90 | 41.30 | 40.70 | 40.90 |
Book Value Per Share | 0.00 | 0.36 | 0.56 | 0.02 | 0.10 |